ACCRA, Ghana--(BUSINESS WIRE)--Yemaachi Biotech, a cancer research and diagnostics company headquartered in Accra, Ghana with offices in Washington, DC, announced today the close of a $3 million seed ...

Experts in oncology have expressed concern over the rising burden of breast and cervical cancers in Africa, noting that over 70 per cent of women present for diagnosis at advanced stages (stages three ...

Triple-negative breast cancer (TNBC), the deadliest breast cancer subtype, disproportionately affects African American women—but until now, they have been underrepresented in genomic studies aimed at ...

Wits scientists have identified a ‘microbial watchlist’ of bacteria, viruses, fungi and parasites that could cause cancer. Thus, targeting common infections in Africa, such as Salmonella typhi and the ...

ACCRA, Ghana & WASHINGTON--(BUSINESS WIRE)--Yemaachi Biotech, a pioneering genomics research company based in Ghana, announced today a partnership with Roche to launch The African Cancer Atlas (TACA).

Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study We conducted a descriptive analysis of GLOBOCAN ...

New research has identified genetic variants associated with breast cancer in Black South African women. Published in Nature Communications, the study identified two genetic variants tied to breast ...

April 13, 2010 — The disproportional impact of lung cancer on African Americans has been highlighted in a new report issued by the American Lung Association. African Americans are more likely to ...

Naomi Oyoe Ohene Oti, a Ghanaian nurse and winner of the Aster Guardians Global Nursing Award, has launched the Cancer Care Africa Foundation to strengthen cancer care delivery across the continent.

Genetic factors contribute to some 30% of breast cancer cases in SA, necessitating investment in genomic research in African contexts. A seminal genetic study published in Nature Communication has ...